NCT07530536 2026-04-15
rTMS for Postoperative Brain Tumor Patients
Columbia University
Phase NA Recruiting
Clinical Trials
25 trialsNCT07496073 2026-03-27
A Phase I, Single-arm, Open-label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Cell Infusion in Adult Subjects With Recurrent or Progressive Malignant Primary Brain Tumors（CROWN）
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Not yet recruiting
NCT04022980 2025-12-30
Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma
Wake Forest University Health Sciences
Phase 1 Completed
NCT03076255 2025-10-15
Using a Head and Neck Maskless Immobilization Device For Patients With Intracranial Tumors
Thomas Jefferson University
Phase NA Completed
NCT06804655 2025-10-02
EViDENCE-BT
University of Zurich
Phase 2 Not yet recruiting
NCT04446962 2025-09-25
LOC-R01
Institut Curie
Phase 1/2 Active not recruiting
NCT07162246 2025-09-09
GK-LIVE
Sunnybrook Health Sciences Centre
Phase 2 Recruiting
NCT04904536 2025-04-10
STRONGER
The George Institute
Phase 3 Active not recruiting
NCT01817751 2024-07-17
Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
Virginia Commonwealth University
Phase 2 Completed
NCT00928226 2024-01-30
Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
Stanford University
Phase NA Completed
NCT02313272 2023-10-23
Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT04475029 2023-09-13
METAMORF
University of Aarhus
Phase NA Completed
NCT01534104 2023-06-09
MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT02343549 2022-11-03
A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)
Wake Forest University Health Sciences
Phase 2 Terminated
NCT01120639 2021-08-06
Tx-Treatment
Stanford University
Phase 1/2 Completed
NCT01969370 2017-05-03
NCGENES
University of North Carolina, Chapel Hill
Phase NA Completed
NCT00360828 2017-03-23
Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
NCT02000986 2015-11-20
Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors
Virginia Commonwealth University
Phase NA Withdrawn
NCT02165163 2015-05-22
Virtual Reality-Based Exercise in Cancer Patients
University of Arizona
Phase NA Completed
NCT00964743 2013-09-09
Depocyt® With Sorafenib in Neoplastic Meningitis
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Terminated
NCT00762255 2013-07-25
A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT00879073 2012-12-18
Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Terminated
NCT00185666 2010-07-14
Cyberknife Precision Radiation Delivery System for Tumors of the Spine
Stanford University
Phase 1/2 Completed
NCT00251797 2010-01-07
A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors
University of New Mexico
Phase 1 Completed
NCT00365222 2009-01-22
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated